Literature DB >> 18665806

Distinct cellular patterns of upregulated chemokine expression supporting a prominent inflammatory role in traumatic brain injury.

Charlotte Israelsson1, Henrik Bengtsson, Annika Kylberg, Klas Kullander, Anders Lewén, Lars Hillered, Ted Ebendal.   

Abstract

Cerebral gene expressions change in response to traumatic brain injury (TBI), and future trauma treatment may improve with increased knowledge about these regulations. We subjected C57BL/6J mice to injury by controlled cortical impact (CCI). At various time points post-injury, mRNA from neocortex and hippocampus was isolated, and transcriptional alterations studied using quantitative real-time polymerase chain reaction (PCR) and gene array analysis. Spatial distribution of enhanced expression was characterized by in situ hybridization. Products of the upregulated transcripts serve functions in a range of cellular mechanisms, including stress, inflammation and immune responses, and tissue remodeling. We also identified increased transcript levels characterizing reactive astrocytes, oligodendrocytes, and microglia, and furthermore, we demonstrated a novel pattern of scattered cell clusters expressing the chemokine Cxcl10. Notably, a sustained increase in integrin alpha X (Itgax), characterizing antigen-presenting dendritic cells, was found with the transcript located to similar cell clusters. In contrast, T-cell receptor alpha transcript showed only a modest increase. The induced P-selectin (Selp) expression level in endothelial cells, and chemokines from microglia, may guide perivascular accumulation of extravasating inflammatory monocytes differentiating into dendritic cells. In conclusion, our study shows that following TBI, secondary injury chiefly involves inflammatory processes and chemokine signaling, which comprise putative targets for pharmaceutical neuroprotection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18665806     DOI: 10.1089/neu.2008.0562

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  63 in total

1.  Expression analysis of the early chemokine response 4 h after in vitro traumatic brain injury.

Authors:  Astrid V Fahlenkamp; Mark Coburn; Michael Czaplik; Yu-Mi Ryang; Markus Kipp; Rolf Rossaint; Cordian Beyer
Journal:  Inflamm Res       Date:  2010-11-23       Impact factor: 4.575

2.  Mild traumatic brain injury-induced hippocampal gene expressions: The identification of target cellular processes for drug development.

Authors:  David Tweedie; Lital Rachmany; Dong Seok Kim; Vardit Rubovitch; Elin Lehrmann; Yongqing Zhang; Kevin G Becker; Evelyn Perez; Chaim G Pick; Nigel H Greig
Journal:  J Neurosci Methods       Date:  2016-02-08       Impact factor: 2.390

3.  Head injury, α-synuclein Rep1, and Parkinson's disease.

Authors:  Samuel M Goldman; Freya Kamel; G Webster Ross; Sarah A Jewell; Grace S Bhudhikanok; David Umbach; Connie Marras; Robert A Hauser; Joseph Jankovic; Stewart A Factor; Susan Bressman; Kelly E Lyons; Cheryl Meng; Monica Korell; Diana F Roucoux; Jane A Hoppin; Dale P Sandler; J William Langston; Caroline M Tanner
Journal:  Ann Neurol       Date:  2012-01       Impact factor: 10.422

Review 4.  Multifunctional drugs for head injury.

Authors:  Robert Vink; Alan J Nimmo
Journal:  Neurotherapeutics       Date:  2009-01       Impact factor: 7.620

Review 5.  Inflammatory reaction after traumatic brain injury: therapeutic potential of targeting cell-cell communication by chemokines.

Authors:  Stefka Gyoneva; Richard M Ransohoff
Journal:  Trends Pharmacol Sci       Date:  2015-05-13       Impact factor: 14.819

6.  Inflammatory consequences in a rodent model of mild traumatic brain injury.

Authors:  J Regino Perez-Polo; Harriet C Rea; Kathia M Johnson; Margaret A Parsley; Geda C Unabia; Guojing Xu; Smitha K Infante; Douglas S Dewitt; Claire E Hulsebosch
Journal:  J Neurotrauma       Date:  2013-05-06       Impact factor: 5.269

7.  Hemorrhagic shock shifts the serum cytokine profile from pro- to anti-inflammatory after experimental traumatic brain injury in mice.

Authors:  Steven L Shein; David K Shellington; Jennifer L Exo; Travis C Jackson; Stephen R Wisniewski; Edwin K Jackson; Vincent A Vagni; Hülya Bayır; Robert S B Clark; C Edward Dixon; Keri L Janesko-Feldman; Patrick M Kochanek
Journal:  J Neurotrauma       Date:  2014-08-15       Impact factor: 5.269

8.  CCR2 deficiency impairs macrophage infiltration and improves cognitive function after traumatic brain injury.

Authors:  Christine L Hsieh; Erene C Niemi; Sarah H Wang; Chih Cheng Lee; Deborah Bingham; Jiasheng Zhang; Myrna L Cozen; Israel Charo; Eric J Huang; Jialing Liu; Mary C Nakamura
Journal:  J Neurotrauma       Date:  2014-07-21       Impact factor: 5.269

9.  APOE genotype-dependent modulation of astrocyte chemokine CCL3 production.

Authors:  Eiron Cudaback; Yue Yang; Thomas J Montine; C Dirk Keene
Journal:  Glia       Date:  2014-08-04       Impact factor: 7.452

10.  Differential patterns of liver proteins in experimental murine hepatosplenic schistosomiasis.

Authors:  B Manivannan; P Rawson; T W Jordan; W E Secor; A C La Flamme
Journal:  Infect Immun       Date:  2009-11-23       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.